140 related articles for article (PubMed ID: 26645253)
1. Increased Risk of Cerebrovascular Disease Among Patients With Neurofibromatosis Type 1: Population-Based Approach.
Terry AR; Jordan JT; Schwamm L; Plotkin SR
Stroke; 2016 Jan; 47(1):60-5. PubMed ID: 26645253
[TBL] [Abstract][Full Text] [Related]
2. Increased Prevalence of Cerebrovascular Disease in Hospitalized Patients with Marfan Syndrome.
Kim ST; Cloft H; Flemming KD; Kallmes DF; Lanzino G; Brinjikji W
J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):296-300. PubMed ID: 29030048
[TBL] [Abstract][Full Text] [Related]
3. Neurofibromatosis type 1 and pregnancy complications: a population-based study.
Terry AR; Barker FG; Leffert L; Bateman BT; Souter I; Plotkin SR
Am J Obstet Gynecol; 2013 Jul; 209(1):46.e1-8. PubMed ID: 23535241
[TBL] [Abstract][Full Text] [Related]
4. Increased Prevalence of Cerebrovascular Disease in Hospitalized Patients with Ehlers-Danlos Syndrome.
Kim ST; Cloft H; Flemming KD; Kallmes DF; Lanzino G; Brinjikji W
J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1678-1682. PubMed ID: 28647420
[TBL] [Abstract][Full Text] [Related]
5. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.
Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ
J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626
[TBL] [Abstract][Full Text] [Related]
6. Epileptic seizures in neurofibromatosis type 1 are related to intracranial tumors but not to neurofibromatosis bright objects.
Hsieh HY; Fung HC; Wang CJ; Chin SC; Wu T
Seizure; 2011 Oct; 20(8):606-11. PubMed ID: 21621428
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors.
Uusitalo E; Kallionpää RA; Kurki S; Rantanen M; Pitkäniemi J; Kronqvist P; Härkönen P; Huovinen R; Carpen O; Pöyhönen M; Peltonen S; Peltonen J
Br J Cancer; 2017 Jan; 116(2):211-217. PubMed ID: 27931045
[TBL] [Abstract][Full Text] [Related]
8. Neuroimaging Findings in Cardiac Myxoma Patients: A Single-Center Case Series of 47 Patients.
Brinjikji W; Morris JM; Brown RD; Thielen KR; Wald JT; Giannini C; Cloft HJ; Wood CP
Cerebrovasc Dis; 2015; 40(1-2):35-44. PubMed ID: 26068450
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of elevated blood pressure among children with neurofibromatosis type 1.
Dubov T; Toledano-Alhadef H; Chernin G; Constantini S; Cleper R; Ben-Shachar S
Pediatr Nephrol; 2016 Jan; 31(1):131-6. PubMed ID: 26314566
[TBL] [Abstract][Full Text] [Related]
10. A controlled register-based study of 460 neurofibromatosis 1 patients: increased fracture risk in children and adults over 41 years of age.
Heervä E; Koffert A; Jokinen E; Kuorilehto T; Peltonen S; Aro HT; Peltonen J
J Bone Miner Res; 2012 Nov; 27(11):2333-7. PubMed ID: 22692994
[TBL] [Abstract][Full Text] [Related]
11. The role of lifestyle factors in the etiology of stroke. A population-based case-control study in Perth, Western Australia.
Jamrozik K; Broadhurst RJ; Anderson CS; Stewart-Wynne EG
Stroke; 1994 Jan; 25(1):51-9. PubMed ID: 8266383
[TBL] [Abstract][Full Text] [Related]
12. Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Lancet; 1996 Aug; 348(9026):505-10. PubMed ID: 8757152
[TBL] [Abstract][Full Text] [Related]
13. Risk of stroke associated with nonsteroidal anti-inflammatory drugs: a nested case-control study.
Bak S; Andersen M; Tsiropoulos I; García Rodríguez LA; Hallas J; Christensen K; Gaist D
Stroke; 2003 Feb; 34(2):379-86. PubMed ID: 12574546
[TBL] [Abstract][Full Text] [Related]
14. Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population.
Zöller ME; Rembeck B; Odén A; Samuelsson M; Angervall L
Cancer; 1997 Jun; 79(11):2125-31. PubMed ID: 9179058
[TBL] [Abstract][Full Text] [Related]
15. [Children with neurofibroma type 1 treated in the Children's Memorial Health Institute].
Perek-Polnik M; Filipek I; Dembowska-Bagińska B; Owsik A; Drogosiewicz M; Jurkiewicz E; Perek D
Med Wieku Rozwoj; 2006; 10(3 Pt 1):699-709. PubMed ID: 17317901
[TBL] [Abstract][Full Text] [Related]
16. Epilepsy in neurofibromatosis type 1: Prevalence, phenotype, and genotype in adults.
Hébert J; De Santis RJ; Daniyal L; Mannan S; Ng E; Thain E; Sanabria-Salas MC; Kim RH; Bril V; Reid AY
Epilepsy Res; 2024 May; 202():107336. PubMed ID: 38471245
[TBL] [Abstract][Full Text] [Related]
17. Nevus Anemicus As an Additional Diagnostic Marker of Neurofibromatosis Type 1 in Childhood.
Vaassen P; Rosenbaum T
Neuropediatrics; 2016 Jun; 47(3):190-3. PubMed ID: 27019377
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of Moyamoya Syndrome in Pediatric Patients With Neurofibromatosis Type 1.
Brosius SN; Vossough A; Fisher MJ; Lang SS; Beslow LA; George BJ; Ichord R
Pediatr Neurol; 2022 Sep; 134():85-92. PubMed ID: 35849956
[TBL] [Abstract][Full Text] [Related]
19. Minor disease features in neurofibromatosis type 1 (NF1) and their possible value in diagnosis of NF1 in children < or = 6 years and clinically suspected of having NF1. Neurofibromatosis team of Sophia Children's Hospital.
Cnossen MH; Moons KG; Garssen MP; Pasmans NM; de Goede-Bolder A; Niermeijer MF; Grobbee DE
J Med Genet; 1998 Aug; 35(8):624-7. PubMed ID: 9719365
[TBL] [Abstract][Full Text] [Related]
20. Congenital anomalies in neurofibromatosis 1: a retrospective register-based total population study.
Leppävirta J; Kallionpää RA; Uusitalo E; Vahlberg T; Pöyhönen M; Peltonen J; Peltonen S
Orphanet J Rare Dis; 2018 Jan; 13(1):5. PubMed ID: 29335026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
